SMI Expanded
1.726,46
PKT
-3,40
PKT
-0,20
%
Werbung
Analysen zu SMI Expanded-Werten
Datum | Rating | Analyst | |
---|---|---|---|
13.11.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
11.11.19 | Roche buy | UBS AG | |
11.11.19 | Roche Neutral | Credit Suisse Group | |
11.11.19 | Roche buy | Goldman Sachs Group Inc. | |
08.11.19 | Zurich Insurance Hold | Deutsche Bank AG | |
07.11.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
07.11.19 | Zurich Insurance Outperform | RBC Capital Markets | |
07.11.19 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
07.11.19 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
07.11.19 | Roche buy | UBS AG | |
06.11.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
06.11.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
04.11.19 | Holcim overweight | Morgan Stanley | |
04.11.19 | UBS buy | Goldman Sachs Group Inc. | |
04.11.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
01.11.19 | Swiss Re Sell | UBS AG | |
01.11.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
01.11.19 | Swiss Re Sector Perform | RBC Capital Markets | |
01.11.19 | UBS buy | Kepler Cheuvreux | |
01.11.19 | Swiss Re kaufen | Credit Suisse Group | |
31.10.19 | Swiss Re Sector Perform | RBC Capital Markets | |
31.10.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
31.10.19 | Swiss Re overweight | Barclays Capital | |
31.10.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
31.10.19 | Novartis Hold | Deutsche Bank AG | |
31.10.19 | UBS buy | Deutsche Bank AG | |
31.10.19 | Swiss Re Sell | UBS AG | |
31.10.19 | UBS Neutral | JP Morgan Chase & Co. | |
30.10.19 | Holcim buy | Goldman Sachs Group Inc. | |
30.10.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
30.10.19 | UBS buy | Goldman Sachs Group Inc. | |
30.10.19 | UBS Equal weight | Barclays Capital | |
30.10.19 | UBS Neutral | JP Morgan Chase & Co. | |
30.10.19 | UBS Equal weight | Barclays Capital | |
30.10.19 | UBS Equal-Weight | Morgan Stanley | |
30.10.19 | UBS Sector Perform | RBC Capital Markets | |
30.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
30.10.19 | UBS buy | UBS AG | |
30.10.19 | Holcim overweight | JP Morgan Chase & Co. | |
29.10.19 | Holcim Equal weight | Barclays Capital |